| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 1.04e-04 | 97 | 20 | 3 | GO:0071013 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 1.04e-04 | 97 | 20 | 3 | GO:0005684 | |
| GeneOntologyCellularComponent | nuclear speck | 6.64e-04 | 431 | 20 | 4 | GO:0016607 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.07e-03 | 215 | 20 | 3 | GO:0005681 | |
| GeneOntologyCellularComponent | U2-type precatalytic spliceosome | 1.08e-03 | 51 | 20 | 2 | GO:0071005 | |
| GeneOntologyCellularComponent | precatalytic spliceosome | 1.21e-03 | 54 | 20 | 2 | GO:0071011 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 1.40e-03 | 1377 | 20 | 6 | GO:0140513 | |
| Domain | Small_GTP-bd_dom | 1.23e-02 | 167 | 19 | 2 | IPR005225 | |
| Pathway | KEGG_SPLICEOSOME | 1.74e-05 | 127 | 18 | 4 | M2044 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.96e-05 | 277 | 18 | 5 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.18e-05 | 283 | 18 | 5 | M13087 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.05e-04 | 201 | 18 | 4 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.29e-04 | 212 | 18 | 4 | M14033 | |
| Pathway | WP_MRNA_PROCESSING | 5.16e-04 | 126 | 18 | 3 | M39406 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 8.11e-04 | 612 | 18 | 5 | MM15547 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 5.75e-09 | 1155 | 20 | 9 | 20360068 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 3.33e-08 | 1415 | 20 | 9 | 28515276 | |
| Pubmed | 4.69e-08 | 1014 | 20 | 8 | 32416067 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.10e-07 | 807 | 20 | 7 | 22681889 | |
| Pubmed | 3.85e-07 | 1335 | 20 | 8 | 29229926 | ||
| Pubmed | 4.94e-07 | 551 | 20 | 6 | 34728620 | ||
| Pubmed | 6.91e-07 | 963 | 20 | 7 | 28671696 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 8.51e-07 | 605 | 20 | 6 | 28977666 | |
| Pubmed | The IgM receptor FcμR limits tonic BCR signaling by regulating expression of the IgM BCR. | 9.42e-07 | 3 | 20 | 2 | 28135254 | |
| Pubmed | Surface receptor Toso controls B cell-mediated regulation of T cell immunity. | 9.42e-07 | 3 | 20 | 2 | 29461978 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.04e-06 | 1024 | 20 | 7 | 24711643 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.50e-06 | 1082 | 20 | 7 | 38697112 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.69e-06 | 154 | 20 | 4 | 16055720 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 28814605 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 31771880 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 28747342 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 24227779 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 14730019 | ||
| Pubmed | B cell-mediated regulatory mechanisms control tumor-promoting intestinal inflammation. | 1.88e-06 | 4 | 20 | 2 | 35830810 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 2.22e-06 | 714 | 20 | 6 | 28302793 | |
| Pubmed | 2.29e-06 | 1153 | 20 | 7 | 29845934 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 11707413 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 3.29e-06 | 182 | 20 | 4 | 32239614 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 4.06e-06 | 1257 | 20 | 7 | 36526897 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 4.51e-06 | 197 | 20 | 4 | 22365833 | |
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 38182585 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 4.92e-06 | 1294 | 20 | 7 | 30804502 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 5.63e-06 | 1321 | 20 | 7 | 27173435 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 6.59e-06 | 1353 | 20 | 7 | 29467282 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | 7.44e-06 | 495 | 20 | 5 | 28581483 | |
| Pubmed | 8.27e-06 | 506 | 20 | 5 | 30890647 | ||
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 11546873 | ||
| Pubmed | TRAP150 activates pre-mRNA splicing and promotes nuclear mRNA degradation. | 8.78e-06 | 8 | 20 | 2 | 20123736 | |
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 9933612 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 9.25e-06 | 1425 | 20 | 7 | 30948266 | |
| Pubmed | 1.13e-05 | 9 | 20 | 2 | 12093754 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.17e-05 | 954 | 20 | 6 | 36373674 | |
| Pubmed | 1.30e-05 | 80 | 20 | 3 | 11991638 | ||
| Pubmed | 1.30e-05 | 80 | 20 | 3 | 25662211 | ||
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 1.31e-05 | 258 | 20 | 4 | 21081666 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.33e-05 | 259 | 20 | 4 | 30404004 | |
| Pubmed | 1.41e-05 | 10 | 20 | 2 | 11546874 | ||
| Pubmed | 1.41e-05 | 10 | 20 | 2 | 33074477 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.43e-05 | 989 | 20 | 6 | 36424410 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 1.61e-05 | 272 | 20 | 4 | 25315684 | |
| Pubmed | 1.65e-05 | 274 | 20 | 4 | 34244482 | ||
| Pubmed | 1.72e-05 | 11 | 20 | 2 | 25849387 | ||
| Pubmed | PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis. | 1.85e-05 | 90 | 20 | 3 | 30699358 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 1.99e-05 | 607 | 20 | 5 | 39147351 | |
| Pubmed | 2.52e-05 | 638 | 20 | 5 | 33239621 | ||
| Pubmed | 2.52e-05 | 638 | 20 | 5 | 31182584 | ||
| Pubmed | 2.80e-05 | 652 | 20 | 5 | 31180492 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 2.89e-05 | 316 | 20 | 4 | 31665637 | |
| Pubmed | 2.97e-05 | 660 | 20 | 5 | 32780723 | ||
| Pubmed | 3.28e-05 | 109 | 20 | 3 | 12226669 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 3.34e-05 | 1149 | 20 | 6 | 35446349 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 3.42e-05 | 330 | 20 | 4 | 33301849 | |
| Pubmed | 3.80e-05 | 339 | 20 | 4 | 30415952 | ||
| Pubmed | 3.85e-05 | 115 | 20 | 3 | 17332742 | ||
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 4.02e-05 | 344 | 20 | 4 | 36282215 | |
| Pubmed | 4.25e-05 | 17 | 20 | 2 | 33305682 | ||
| Pubmed | 4.58e-05 | 723 | 20 | 5 | 34133714 | ||
| Pubmed | 4.83e-05 | 731 | 20 | 5 | 29298432 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 4.86e-05 | 732 | 20 | 5 | 34732716 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 4.95e-05 | 363 | 20 | 4 | 14691545 | |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 6.16e-05 | 384 | 20 | 4 | 31059266 | |
| Pubmed | 7.15e-05 | 399 | 20 | 4 | 35987950 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 7.18e-05 | 1318 | 20 | 6 | 30463901 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 8.49e-05 | 150 | 20 | 3 | 28242625 | |
| Pubmed | The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA. | 8.61e-05 | 24 | 20 | 2 | 24798327 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 8.79e-05 | 1367 | 20 | 6 | 32687490 | |
| Pubmed | 9.12e-05 | 425 | 20 | 4 | 21081503 | ||
| Pubmed | 9.68e-05 | 847 | 20 | 5 | 35850772 | ||
| Pubmed | 1.12e-04 | 1429 | 20 | 6 | 35140242 | ||
| Pubmed | 1.15e-04 | 451 | 20 | 4 | 36168627 | ||
| Pubmed | 1.17e-04 | 167 | 20 | 3 | 35833506 | ||
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 1.21e-04 | 169 | 20 | 3 | 23084401 | |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 1.23e-04 | 170 | 20 | 3 | 16159877 | |
| Pubmed | 1.27e-04 | 463 | 20 | 4 | 34901782 | ||
| Pubmed | 1.33e-04 | 469 | 20 | 4 | 37314180 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.42e-04 | 477 | 20 | 4 | 31300519 | |
| Pubmed | 1.50e-04 | 484 | 20 | 4 | 31995728 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.53e-04 | 486 | 20 | 4 | 30940648 | |
| Pubmed | 1.53e-04 | 183 | 20 | 3 | 36129980 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.53e-04 | 934 | 20 | 5 | 33916271 | |
| Pubmed | Proteomic analysis of complexes formed by human topoisomerase I. | 1.54e-04 | 32 | 20 | 2 | 15848144 | |
| Pubmed | 1.63e-04 | 494 | 20 | 4 | 26831064 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 1.65e-04 | 949 | 20 | 5 | 36574265 | |
| Pubmed | 1.74e-04 | 34 | 20 | 2 | 15146077 | ||
| Pubmed | 1.84e-04 | 971 | 20 | 5 | 33306668 | ||
| Pubmed | 1.90e-04 | 197 | 20 | 3 | 31620119 | ||
| Pubmed | 2.07e-04 | 37 | 20 | 2 | 7584028 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.63e-04 | 220 | 20 | 3 | 35785414 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 2.63e-04 | 220 | 20 | 3 | 34091597 | |
| Pubmed | 2.67e-04 | 42 | 20 | 2 | 34581821 | ||
| Pubmed | 2.80e-04 | 43 | 20 | 2 | 7584026 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 2.84e-04 | 226 | 20 | 3 | 37839992 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 2.86e-04 | 573 | 20 | 4 | 28330616 | |
| Pubmed | 3.06e-04 | 45 | 20 | 2 | 27512140 | ||
| Pubmed | 3.15e-04 | 234 | 20 | 3 | 36243803 | ||
| Interaction | UPF3B interactions | 1.86e-07 | 136 | 20 | 5 | int:UPF3B | |
| Interaction | DDX5 interactions | 7.67e-07 | 568 | 20 | 7 | int:DDX5 | |
| Interaction | PRMT1 interactions | 1.52e-06 | 929 | 20 | 8 | int:PRMT1 | |
| Interaction | SUZ12 interactions | 1.78e-06 | 644 | 20 | 7 | int:SUZ12 | |
| Interaction | LUZP4 interactions | 2.50e-06 | 99 | 20 | 4 | int:LUZP4 | |
| Interaction | IFI16 interactions | 3.52e-06 | 714 | 20 | 7 | int:IFI16 | |
| Interaction | RBM39 interactions | 3.59e-06 | 1042 | 20 | 8 | int:RBM39 | |
| Interaction | EED interactions | 3.97e-06 | 1445 | 20 | 9 | int:EED | |
| Interaction | EFTUD2 interactions | 4.07e-06 | 1449 | 20 | 9 | int:EFTUD2 | |
| Interaction | RBM8A interactions | 4.75e-06 | 473 | 20 | 6 | int:RBM8A | |
| Interaction | ISY1-RAB43 interactions | 7.47e-06 | 39 | 20 | 3 | int:ISY1-RAB43 | |
| Interaction | OBSL1 interactions | 1.63e-05 | 902 | 20 | 7 | int:OBSL1 | |
| Interaction | HEXIM1 interactions | 1.77e-05 | 913 | 20 | 7 | int:HEXIM1 | |
| Interaction | TUBGCP6 interactions | 3.20e-05 | 63 | 20 | 3 | int:TUBGCP6 | |
| Interaction | TPM3 interactions | 3.23e-05 | 390 | 20 | 5 | int:TPM3 | |
| Interaction | GRWD1 interactions | 3.23e-05 | 390 | 20 | 5 | int:GRWD1 | |
| Interaction | RECQL4 interactions | 3.35e-05 | 1412 | 20 | 8 | int:RECQL4 | |
| Interaction | LSM2 interactions | 3.36e-05 | 191 | 20 | 4 | int:LSM2 | |
| Interaction | KDF1 interactions | 3.43e-05 | 192 | 20 | 4 | int:KDF1 | |
| Interaction | SOX2 interactions | 3.52e-05 | 1422 | 20 | 8 | int:SOX2 | |
| Interaction | SUPT5H interactions | 4.00e-05 | 408 | 20 | 5 | int:SUPT5H | |
| Interaction | ACTC1 interactions | 4.18e-05 | 694 | 20 | 6 | int:ACTC1 | |
| Interaction | LSG1 interactions | 4.27e-05 | 203 | 20 | 4 | int:LSG1 | |
| Interaction | PABPC1 interactions | 4.35e-05 | 699 | 20 | 6 | int:PABPC1 | |
| Interaction | SNIP1 interactions | 4.44e-05 | 417 | 20 | 5 | int:SNIP1 | |
| Interaction | TFIP11 interactions | 4.97e-05 | 427 | 20 | 5 | int:TFIP11 | |
| Interaction | RANBP9 interactions | 5.31e-05 | 433 | 20 | 5 | int:RANBP9 | |
| Interaction | HNRNPA2B1 interactions | 6.64e-05 | 754 | 20 | 6 | int:HNRNPA2B1 | |
| Interaction | CHD3 interactions | 6.79e-05 | 757 | 20 | 6 | int:CHD3 | |
| Interaction | UTP14A interactions | 6.94e-05 | 230 | 20 | 4 | int:UTP14A | |
| Interaction | CD2BP2 interactions | 7.17e-05 | 232 | 20 | 4 | int:CD2BP2 | |
| Interaction | LARP1 interactions | 7.45e-05 | 465 | 20 | 5 | int:LARP1 | |
| Interaction | NFX1 interactions | 7.53e-05 | 466 | 20 | 5 | int:NFX1 | |
| Interaction | TXLNA interactions | 7.66e-05 | 236 | 20 | 4 | int:TXLNA | |
| Interaction | SRP19 interactions | 8.72e-05 | 244 | 20 | 4 | int:SRP19 | |
| Interaction | DOT1L interactions | 9.68e-05 | 807 | 20 | 6 | int:DOT1L | |
| Interaction | PRPS2 interactions | 1.00e-04 | 253 | 20 | 4 | int:PRPS2 | |
| Interaction | SNRPB2 interactions | 1.03e-04 | 255 | 20 | 4 | int:SNRPB2 | |
| Interaction | HNRNPA3 interactions | 1.16e-04 | 511 | 20 | 5 | int:HNRNPA3 | |
| Interaction | MAGOH interactions | 1.18e-04 | 264 | 20 | 4 | int:MAGOH | |
| Interaction | MAPRE1 interactions | 1.19e-04 | 514 | 20 | 5 | int:MAPRE1 | |
| Interaction | TXLNG interactions | 1.20e-04 | 98 | 20 | 3 | int:TXLNG | |
| Interaction | SEMA3F interactions | 1.26e-04 | 17 | 20 | 2 | int:SEMA3F | |
| Interaction | SF3A2 interactions | 1.35e-04 | 273 | 20 | 4 | int:SF3A2 | |
| Interaction | AFG2B interactions | 1.39e-04 | 103 | 20 | 3 | int:AFG2B | |
| Interaction | RNF2 interactions | 1.43e-04 | 866 | 20 | 6 | int:RNF2 | |
| Interaction | ZC3H18 interactions | 1.53e-04 | 877 | 20 | 6 | int:ZC3H18 | |
| Interaction | MECP2 interactions | 1.58e-04 | 1287 | 20 | 7 | int:MECP2 | |
| Interaction | ZNF383 interactions | 1.58e-04 | 19 | 20 | 2 | int:ZNF383 | |
| Interaction | WBP4 interactions | 1.64e-04 | 109 | 20 | 3 | int:WBP4 | |
| Interaction | TRIP10 interactions | 1.64e-04 | 109 | 20 | 3 | int:TRIP10 | |
| Interaction | USP10 interactions | 1.70e-04 | 290 | 20 | 4 | int:USP10 | |
| Interaction | EMC4 interactions | 1.74e-04 | 292 | 20 | 4 | int:EMC4 | |
| Interaction | PARP1 interactions | 1.81e-04 | 1316 | 20 | 7 | int:PARP1 | |
| Interaction | PPWD1 interactions | 1.83e-04 | 113 | 20 | 3 | int:PPWD1 | |
| Interaction | ING5 interactions | 1.87e-04 | 114 | 20 | 3 | int:ING5 | |
| Interaction | DDX39B interactions | 1.94e-04 | 570 | 20 | 5 | int:DDX39B | |
| Interaction | SRSF1 interactions | 1.94e-04 | 570 | 20 | 5 | int:SRSF1 | |
| Interaction | BIRC3 interactions | 1.98e-04 | 1334 | 20 | 7 | int:BIRC3 | |
| Interaction | RBM6 interactions | 2.13e-04 | 119 | 20 | 3 | int:RBM6 | |
| Interaction | CHD4 interactions | 2.21e-04 | 938 | 20 | 6 | int:CHD4 | |
| Interaction | PPM1H interactions | 2.34e-04 | 123 | 20 | 3 | int:PPM1H | |
| Interaction | CDC40 interactions | 2.40e-04 | 124 | 20 | 3 | int:CDC40 | |
| Interaction | GLDC interactions | 2.50e-04 | 321 | 20 | 4 | int:GLDC | |
| Interaction | NSUN2 interactions | 2.56e-04 | 323 | 20 | 4 | int:NSUN2 | |
| Interaction | EBNA1BP2 interactions | 2.59e-04 | 324 | 20 | 4 | int:EBNA1BP2 | |
| Interaction | ZNF746 interactions | 2.65e-04 | 326 | 20 | 4 | int:ZNF746 | |
| Interaction | PRC1 interactions | 2.70e-04 | 973 | 20 | 6 | int:PRC1 | |
| Interaction | ARHGAP35 interactions | 2.76e-04 | 130 | 20 | 3 | int:ARHGAP35 | |
| Interaction | EIF3J interactions | 2.76e-04 | 130 | 20 | 3 | int:EIF3J | |
| Interaction | RBM42 interactions | 2.81e-04 | 331 | 20 | 4 | int:RBM42 | |
| Interaction | SRP72 interactions | 2.88e-04 | 333 | 20 | 4 | int:SRP72 | |
| Interaction | PYM1 interactions | 2.95e-04 | 133 | 20 | 3 | int:PYM1 | |
| Interaction | DDX59 interactions | 3.00e-04 | 26 | 20 | 2 | int:DDX59 | |
| Interaction | AVEN interactions | 3.00e-04 | 26 | 20 | 2 | int:AVEN | |
| Interaction | ISY1 interactions | 3.08e-04 | 135 | 20 | 3 | int:ISY1 | |
| Interaction | RBM5 interactions | 3.08e-04 | 135 | 20 | 3 | int:RBM5 | |
| Interaction | SMC5 interactions | 3.13e-04 | 1000 | 20 | 6 | int:SMC5 | |
| Interaction | PKP3 interactions | 3.15e-04 | 136 | 20 | 3 | int:PKP3 | |
| Interaction | CEBPB interactions | 3.21e-04 | 1443 | 20 | 7 | int:CEBPB | |
| Interaction | LSM3 interactions | 3.36e-04 | 139 | 20 | 3 | int:LSM3 | |
| Interaction | SRRM1 interactions | 3.40e-04 | 348 | 20 | 4 | int:SRRM1 | |
| Interaction | RNU11 interactions | 3.48e-04 | 28 | 20 | 2 | int:RNU11 | |
| Interaction | RNU12 interactions | 3.48e-04 | 28 | 20 | 2 | int:RNU12 | |
| Interaction | UBE2M interactions | 3.59e-04 | 651 | 20 | 5 | int:UBE2M | |
| Interaction | SMARCC2 interactions | 3.59e-04 | 353 | 20 | 4 | int:SMARCC2 | |
| Interaction | LUC7L2 interactions | 3.59e-04 | 353 | 20 | 4 | int:LUC7L2 | |
| Interaction | EIF2A interactions | 3.73e-04 | 144 | 20 | 3 | int:EIF2A | |
| Interaction | CHTF8 interactions | 3.74e-04 | 29 | 20 | 2 | int:CHTF8 | |
| Interaction | TOE1 interactions | 3.88e-04 | 146 | 20 | 3 | int:TOE1 | |
| Interaction | NUPR1 interactions | 4.47e-04 | 683 | 20 | 5 | int:NUPR1 | |
| Interaction | SEPHS2 interactions | 4.56e-04 | 32 | 20 | 2 | int:SEPHS2 | |
| Interaction | PARK7 interactions | 4.70e-04 | 379 | 20 | 4 | int:PARK7 | |
| Interaction | SRP68 interactions | 4.79e-04 | 381 | 20 | 4 | int:SRP68 | |
| Interaction | SMARCC1 interactions | 4.94e-04 | 384 | 20 | 4 | int:SMARCC1 | |
| Interaction | GNL2 interactions | 5.03e-04 | 386 | 20 | 4 | int:GNL2 | |
| Interaction | YLPM1 interactions | 5.07e-04 | 160 | 20 | 3 | int:YLPM1 | |
| Interaction | WBP11 interactions | 5.07e-04 | 160 | 20 | 3 | int:WBP11 | |
| Interaction | RPL10 interactions | 5.07e-04 | 702 | 20 | 5 | int:RPL10 | |
| Interaction | DRG1 interactions | 5.13e-04 | 388 | 20 | 4 | int:DRG1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q32 | 2.63e-04 | 290 | 20 | 3 | chr1q32 | |
| Cytoband | 1q32.1 | 1.01e-03 | 108 | 20 | 2 | 1q32.1 | |
| Cytoband | 16q22.1 | 1.05e-03 | 110 | 20 | 2 | 16q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 2.86e-03 | 183 | 20 | 2 | chr16q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.78e-02 | 473 | 20 | 2 | chr17q21 | |
| GeneFamily | Immunoglobulin like domain containing | 8.18e-03 | 193 | 13 | 2 | 594 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.15e-02 | 394 | 13 | 2 | 471 | |
| Coexpression | GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN | 1.39e-05 | 198 | 20 | 4 | M7249 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON | 4.29e-05 | 13 | 20 | 2 | M1207 | |
| Coexpression | GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP | 1.91e-04 | 149 | 20 | 3 | M8918 | |
| Coexpression | GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP | 3.61e-04 | 185 | 20 | 3 | M5643 | |
| Coexpression | GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP | 4.21e-04 | 195 | 20 | 3 | M3089 | |
| Coexpression | GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 4.40e-04 | 198 | 20 | 3 | M4249 | |
| Coexpression | GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 4.40e-04 | 198 | 20 | 3 | M5335 | |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP | 4.47e-04 | 199 | 20 | 3 | M3328 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP | 4.47e-04 | 199 | 20 | 3 | M4473 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP | 4.47e-04 | 199 | 20 | 3 | M4481 | |
| Coexpression | GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP | 4.47e-04 | 199 | 20 | 3 | M3182 | |
| Coexpression | GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_DN | 4.53e-04 | 200 | 20 | 3 | M9029 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_DN | 4.53e-04 | 200 | 20 | 3 | M3752 | |
| Coexpression | GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN | 4.53e-04 | 200 | 20 | 3 | M8524 | |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN | 4.53e-04 | 200 | 20 | 3 | M7473 | |
| Coexpression | GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP | 4.53e-04 | 200 | 20 | 3 | M7365 | |
| Coexpression | GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN | 4.53e-04 | 200 | 20 | 3 | M6949 | |
| CoexpressionAtlas | B cells, B1b.PC, IgD+ IgM+ CD19+ CD43+ CD5+ CD45R+, Peritoneal Cavity, avg-1 | 7.67e-04 | 46 | 19 | 2 | GSM538230_100 | |
| CoexpressionAtlas | B cells, B1a.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23- CD21/35-, Spleen, avg-3 | 7.67e-04 | 46 | 19 | 2 | GSM538225_100 | |
| CoexpressionAtlas | B cells, B1b.PC, IgD+ IgM+ CD19+ CD43+ CD5- CD45R+, Peritoneal Cavity, avg-2 | 8.35e-04 | 48 | 19 | 2 | GSM538228_100 | |
| CoexpressionAtlas | B cells, B1a.PC, IgD+ IgM+ CD19+ CD43+ CD5+ CD45R+, Peritoneal Cavity, avg-3 | 8.70e-04 | 49 | 19 | 2 | GSM538222_100 | |
| CoexpressionAtlas | B cells, B1a.Sp, CD19+ CD45R+ IgM++ AA4.1- CD23- CD43+ CD5+, Spleen, avg-3 | 8.70e-04 | 49 | 19 | 2 | GSM854229_100 | |
| CoexpressionAtlas | B cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3 | 1.02e-03 | 53 | 19 | 2 | GSM538198_100 | |
| CoexpressionAtlas | B cells, B.Fo.MLN, CD19+ CD45R+ CD23+ CD21/35+, Lymph Node, avg-3 | 1.02e-03 | 53 | 19 | 2 | GSM777021_100 | |
| CoexpressionAtlas | CD positive, CD19 Control, 19+ 4- 8-, Spleen, avg-6 | 1.06e-03 | 54 | 19 | 2 | GSM403988_100 | |
| CoexpressionAtlas | B cells, B.T1.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23-, Spleen, avg-3 | 1.06e-03 | 54 | 19 | 2 | GSM538213_100 | |
| CoexpressionAtlas | B cells, B.T2.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3 | 1.06e-03 | 54 | 19 | 2 | GSM538216_100 | |
| CoexpressionAtlas | B cells, B.Fo.LN, CD19+ CD45R+ CD23+ CD21/35+, Lymph Node, avg-2 | 1.06e-03 | 54 | 19 | 2 | GSM777019_100 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | 1.06e-03 | 54 | 19 | 2 | GSM538207_100 | |
| CoexpressionAtlas | B cells, B.Fo.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23+, Spleen, avg-3 | 1.10e-03 | 55 | 19 | 2 | GSM538201_100 | |
| CoexpressionAtlas | B cells, B.T3.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3 | 1.13e-03 | 56 | 19 | 2 | GSM538219_100 | |
| CoexpressionAtlas | B cells, B.FrF.BM, CD19+ IgM+ AA4.1- HSA+, Bone marrow, avg-3 | 1.22e-03 | 58 | 19 | 2 | GSM399440_100 | |
| CoexpressionAtlas | B cells, B.MZ.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23- CD21/35+, Spleen, avg-2 | 1.22e-03 | 58 | 19 | 2 | GSM538211_100 | |
| CoexpressionAtlas | B cells, B.MZ.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23- CD21.35+, Spleen, avg-1 | 1.22e-03 | 58 | 19 | 2 | GSM538210_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.25e-03 | 243 | 19 | 3 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000 | |
| CoexpressionAtlas | B cells, B.FrE.BM, CD19+ IgM+ AA4.1+ HSA+, Bone marrow, avg-3 | 1.26e-03 | 59 | 19 | 2 | GSM399438_100 | |
| CoexpressionAtlas | B cells, B.FrE.FL, AA4.1+ IgM+ CD19+ CD43- CD24+, Fetal Liver, avg-3 | 1.30e-03 | 60 | 19 | 2 | GSM538204_100 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-05 | 167 | 20 | 3 | 4520ee71e2b119c1dfa0e342fe57eda5f3598650 | |
| ToppCell | facs-BAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-05 | 175 | 20 | 3 | 46d6e319f8ca46592f23257800bcb6d228fffbbe | |
| ToppCell | background-B_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.14e-05 | 191 | 20 | 3 | a189fdc9c739bb0801e2f38af0932a1ea615cb34 | |
| ToppCell | critical-Lymphoid-B_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.14e-05 | 191 | 20 | 3 | 0716cfaeb11d9c90c18fa8f9d50c9c6fb5182848 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.27e-05 | 192 | 20 | 3 | 80a71ab3434076803466ccac0df73468889c7dd3 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.27e-05 | 192 | 20 | 3 | 75ce635d669ff77d1fd54e10467f21d5e5d67b08 | |
| ToppCell | NS-critical-d_16-33|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.66e-05 | 195 | 20 | 3 | 0f6c435904b4231053f8a38f7f9f2b34532ce214 | |
| ToppCell | droplet-Marrow-BM-1m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 195 | 20 | 3 | 637b06ef3967b03f7165d102d316e8b7161a817d | |
| ToppCell | NS-critical-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.66e-05 | 195 | 20 | 3 | 1ce4c9ab82212f399ddba9784d2bcec70b6b98b2 | |
| ToppCell | normal_Lymph_Node|World / Location, Cell class and cell subclass | 8.66e-05 | 195 | 20 | 3 | 4ae6ce15ca8400fc6b36fc4da8479aab295e488e | |
| ToppCell | NS-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.66e-05 | 195 | 20 | 3 | 1c0d8dbe8490c35903061469e395b218416b1aa2 | |
| ToppCell | 10x5'-lymph-node_spleen|World / Manually curated celltypes from each tissue | 8.79e-05 | 196 | 20 | 3 | 2951be22ab9095c4d3286c69dc4ab3308287c145 | |
| ToppCell | NS-critical-d_16-33-Lymphoid|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.92e-05 | 197 | 20 | 3 | c6c33f8e2cfd4c6853e77bc3ad334ae41069758c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.19e-05 | 199 | 20 | 3 | 8bc07beace200ae2ad41e932b72fdcc7ff08b812 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.25e-04 | 83 | 20 | 2 | 48db75711526364d2a8165524d3cbb92129ddba3 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.09e-03 | 110 | 20 | 2 | 3639fb5fc02eca509cb220295bc3e6064c23baab | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Zbtb20_(Ventral_Hippocampus)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.09e-03 | 110 | 20 | 2 | ff196c71aa2a21cdd812958bd163fa6b91bd2352 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Zbtb20_(Ventral_Hippocampus)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.09e-03 | 110 | 20 | 2 | 46635a130453c2fa304f0e09561b2a267c9ceb31 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.09e-03 | 110 | 20 | 2 | 438bf761ab0a25e3dc9244c23ae2c2d68a169c7f | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-03 | 110 | 20 | 2 | f626f0fdd1bff9c4970af14524ebdbdad8b67178 | |
| ToppCell | Lymphoid-B_cells_(cycle)|World / shred on cell class and cell subclass (v4) | 1.11e-03 | 111 | 20 | 2 | df23af931ce0258ce97d6b4c7125ae1ab16a7eaa | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.17e-03 | 114 | 20 | 2 | 1c99483a492d08b6bb745006fe24c22841dc57ad | |
| ToppCell | PND01-03-samps-Lymphocyte-B_cell-B_cell_1|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.48e-03 | 128 | 20 | 2 | 5d82247ceda55017628720ed8b6c36ff7cec8437 | |
| ToppCell | PND01-03-samps-Lymphocyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.48e-03 | 128 | 20 | 2 | d3158825a2178244b57ac5ad2676617fd58d8466 | |
| ToppCell | PND01-03-samps-Lymphocyte-B_cell|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.48e-03 | 128 | 20 | 2 | 7661402dd7cd533c1bfe8d9247cecd88c1be9a5e | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2-Excitatory_Neuron.Slc17a7.C1ql2-Cck_(Dentate_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.50e-03 | 129 | 20 | 2 | 08ecebb7f09d105dfdfd2191fc310910d3baec0f | |
| ToppCell | COVID-19-B_cells-B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.52e-03 | 130 | 20 | 2 | 267b06a0db31e2664cf595cd737402da07ab51cd | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-03 | 131 | 20 | 2 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-03 | 135 | 20 | 2 | 7743a01dc9c4542e910e7c0fe046004692a680bf | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell-B_cell_2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.69e-03 | 137 | 20 | 2 | 2544d1256f11da6e3bad24a871b2253e0ab20d01 | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.69e-03 | 137 | 20 | 2 | 874e2eaa7846a2832f46b77c726d79f220a4a1cd | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-03 | 140 | 20 | 2 | af9efcbaeeae69fcdac4a15fa244728b65915564 | |
| ToppCell | normal_Lung-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 1.76e-03 | 140 | 20 | 2 | 3f003320d797f18d2dfc38eab7f094f75027958e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-B_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.89e-03 | 145 | 20 | 2 | 34cff6df39ff05995041f0c231c60a50ad1a0c1c | |
| ToppCell | P15-Hematopoietic|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.91e-03 | 146 | 20 | 2 | 2b3e6ff6069573ee213000aeab5de9a33afc1a99 | |
| ToppCell | Lymphoid-B_cells|World / shred on cell class and cell subclass (v4) | 1.94e-03 | 147 | 20 | 2 | aa4486200c523f2c9d3bad7a14f1764c2d92076b | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-03 | 148 | 20 | 2 | b78dac56b333bf901136ccafb0999f345e978f51 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-03 | 149 | 20 | 2 | a6e192bf9bcf3b219e618c465bc451f7c86f49f1 | |
| ToppCell | PND28|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-03 | 149 | 20 | 2 | d3a025440c8ad284a9291c902403e5888d28e90b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.99e-03 | 149 | 20 | 2 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-03 | 150 | 20 | 2 | d6b977dd47aa017f6ba762f0c505cd896caa523f | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-03 | 150 | 20 | 2 | d9931507257c64ead4a53786e6822f51962c6015 | |
| ToppCell | Lymphoid-Lymphoid-B_cells|Lymphoid / shred on cell class and cell subclass (v4) | 2.02e-03 | 150 | 20 | 2 | 5ebf6b4b9b029422a4676ba09a6a9225bd25db47 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-03 | 150 | 20 | 2 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-03 | 150 | 20 | 2 | cc8361bdcaa16ab6a0d6a3684690d709bc42ff3b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-03 | 150 | 20 | 2 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | Lymphoid|World / shred on cell class and cell subclass (v4) | 2.04e-03 | 151 | 20 | 2 | d7577b2416b91a8be0198dea703385f86f816059 | |
| ToppCell | P15-Hematopoietic-Immune|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.04e-03 | 151 | 20 | 2 | a54045cac65a66197e3ad2b002fa6c511102834a | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.04e-03 | 151 | 20 | 2 | 0f8f07e44c6edaf09574930b416fdce14d67095a | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-03 | 151 | 20 | 2 | ee56b88c56c3b6a5ec9644c43cae521ea0e05920 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-03 | 151 | 20 | 2 | 2c239b09970acbaa90c5ebe1097f453c516f868e | |
| ToppCell | P15-Hematopoietic-Immune-immune_cell_unspecified|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.04e-03 | 151 | 20 | 2 | 6b905d309f2a9b8828399b36f4942aec8696bee6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-B_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.07e-03 | 152 | 20 | 2 | 66f9190de155251a63a7a669374f342a75d22ea0 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-03 | 152 | 20 | 2 | b750302d442160a1007659c2386ac90282bf95d2 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-03 | 153 | 20 | 2 | a8f83ec640fae51d4fba34b92e3d6cca4999e930 | |
| ToppCell | Healthy-B_cell|Healthy / disease group, cell group and cell class | 2.10e-03 | 153 | 20 | 2 | 7f82cd61b3f1ebaee3e4bbf68ba858a67c2065e7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-03 | 154 | 20 | 2 | 3fa6f77ad2c30ec24b9b904e2732ec5b419dff5b | |
| ToppCell | P28-Hematopoietic|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.12e-03 | 154 | 20 | 2 | 13980ae1957b05350c11171c9c118decfe998d3d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-03 | 154 | 20 | 2 | ee03b386d28a524084eaf1c0091f7389daa34250 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue | 2.12e-03 | 154 | 20 | 2 | 2b7d7f09c75bbc22de1358fc44b8ad5d3f656617 | |
| ToppCell | facs-Trachea-24m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.12e-03 | 154 | 20 | 2 | 75897e35b0e22811a30f8e63ebe65b43aa714f0d | |
| ToppCell | Adult-Immune-B_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.15e-03 | 155 | 20 | 2 | 5857aebd43b901fc9f8c46f2d628582969db9e6a | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-03 | 155 | 20 | 2 | efe69145910c5e049d0ed30699c26ef963e0a285 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 155 | 20 | 2 | c465a22abc2b9705b6b0fc4753980f790ab8ec5e | |
| ToppCell | facs-Pancreas-Exocrine-24m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 155 | 20 | 2 | 6ade33c274d35ae5531956f70526005d1d5e277b | |
| ToppCell | facs-Pancreas-Exocrine-24m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 155 | 20 | 2 | 0dec58d76e3f8cff9d62eaa4adb21a1dc7fd7487 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.18e-03 | 156 | 20 | 2 | d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.18e-03 | 156 | 20 | 2 | 55ba43cec9d79f309e9f633a6469cf03bb621e64 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.18e-03 | 156 | 20 | 2 | 6f8622716bad4e505f241a2a4ef953bf3fc6dbfa | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.18e-03 | 156 | 20 | 2 | 44ff0acdd5cc3575d6c24a1c2ba11cd9f55359d1 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.18e-03 | 156 | 20 | 2 | a5930b455e5c8586c43c50106ab4d8a1e5e9e3d6 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-03 | 157 | 20 | 2 | b337937a88f62030114a28d70a63168417672767 | |
| ToppCell | P28-Hematopoietic-Immune-immune_cell_unspecified|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.21e-03 | 157 | 20 | 2 | a70f93aff07b6b7a9efce33b12b024116648dc0a | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-03 | 157 | 20 | 2 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-03 | 157 | 20 | 2 | a9e077f686382303f0437ebfa4f11d273ba9fe40 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-03 | 157 | 20 | 2 | 14c4c61790eba6a388679e6d5011424d56cf3b5a | |
| ToppCell | P28-Hematopoietic-Immune|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.21e-03 | 157 | 20 | 2 | b1f520b1e0ea7abb19d0dd27021eafbea0fd90cd | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Lymphocytic-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-03 | 158 | 20 | 2 | 98fd640ef0bd0014b8c38b81bd5160efcf42f23c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Lymphocytic|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-03 | 158 | 20 | 2 | 4d2d69fbb880b5232d7867b4d099d0f047ca9ebe | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-03 | 158 | 20 | 2 | 66c011e9de002224f70725dfe8e7871c8d304492 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-03 | 159 | 20 | 2 | 74655c22e9fdd88e3052b9dfb954c8fb678bd2d8 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-03 | 159 | 20 | 2 | f0611a7bf15e2f7dfe828dd247650a30b3d6d44d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-03 | 159 | 20 | 2 | 997963d879e5819683793cddf5e1acff1b81a1b8 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 2.26e-03 | 159 | 20 | 2 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-03 | 159 | 20 | 2 | 048b6a97568242c8846034277680632e5de75840 | |
| ToppCell | droplet-Liver-LIVER_NPC|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-03 | 159 | 20 | 2 | e4eaa88772835d6b78e1a18a0cec52de51e80339 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-03 | 159 | 20 | 2 | 656aa20706bdba81bbcc3e68e6058215b92b8802 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 160 | 20 | 2 | 1cb6f42b68c9e41e8edae0de8f0d8371c4620b04 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.29e-03 | 160 | 20 | 2 | 5744cd30709f38e84f7ec8893dc19d7a288b465a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 160 | 20 | 2 | 6bafbe2b4b98bc088406a516d079093f89d9c344 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.29e-03 | 160 | 20 | 2 | 8396afbc7d919ba190863d50aa0ef8b9942a9866 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 160 | 20 | 2 | cfd005e98944817458e8ef9e0c436d77f50c1ad1 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 160 | 20 | 2 | 5c9281706009558c8361bfa76169f43ffc0f7947 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-03 | 160 | 20 | 2 | 778faada072e3abfa76a9a06fd4885fb63de7902 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.29e-03 | 160 | 20 | 2 | 7ad065337ac802de52c15ee715f6b78a3eed0cef | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 160 | 20 | 2 | ebefde92db400cbe68d9ce31545a0308e0afbde1 | |
| ToppCell | droplet-Fat-Scat-21m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-03 | 161 | 20 | 2 | e52735f955f0a53da5cbe5a2d77a00484e5109b3 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-03 | 161 | 20 | 2 | 98be0cf8228496b31f7f3e0efd8787e95eb626d1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-03 | 161 | 20 | 2 | 249c2b97cc25de5053f5048ee354615df49b2081 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-03 | 161 | 20 | 2 | 7af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af | |
| Disease | microcephaly (is_implicated_in) | 1.10e-05 | 8 | 19 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 4.72e-04 | 50 | 19 | 2 | EFO_0010732 | |
| Disease | Mouth Neoplasms | 5.51e-04 | 54 | 19 | 2 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 5.51e-04 | 54 | 19 | 2 | C0153381 | |
| Disease | Squamous cell carcinoma | 2.86e-03 | 124 | 19 | 2 | C0007137 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLGVDMDDKDDAHYA | 526 | Q9BZE4 | |
| DSYDFDDKSMQGDDP | 451 | Q9NZW4 | |
| HDGEYDSPEDDMNDR | 316 | Q9NQ90 | |
| PDKHDGDKYPMESDN | 1651 | Q96SN8 | |
| SDDDVEETHPMDGND | 156 | Q9P2K3 | |
| EETHPMDGNDSDYDP | 161 | Q9P2K3 | |
| SDSEMEMEAEHYPNG | 451 | Q6VN20 | |
| DLHEAGGEDFAMDED | 6 | Q9Y5S9 | |
| SDYDMHTGDPKQDLA | 21 | Q9Y262 | |
| MADEGKSYSEHDDER | 1 | Q9UBU9 | |
| DFSMYHPDDEADEMK | 1411 | A2PYH4 | |
| GPNHEEDADSYENMD | 521 | P15391 | |
| YKMADEAGSEADHEG | 601 | P02671 | |
| AEDPDDYDDGFSMKH | 176 | Q969G3 | |
| YQESMDTDKDDPHGR | 46 | O00327 | |
| PSTDSHMDEDGFEKD | 766 | P78536 | |
| EDPLAGDQNDHDMDS | 546 | O75044 | |
| HQPAAMMEDSDSDDY | 371 | O60667 | |
| EMDYEEADNDPTGEA | 186 | Q15393 | |
| PIDFEKDDDSNFHMD | 846 | P22314 | |
| DGYPEDMDQDKHDDS | 256 | Q9Y2W2 | |
| DDDDVGDHDDDHPGM | 41 | Q15029 |